CAS: 467-04-9 - oripavine
Fórmula:C18H19NO3
InChI:InChI=1S/C18H19NO3/c1-19-8-7-18-11-4-6-14(21-2)17(18)22-16-13(20)5-3-10(15(16)18)9-12(11)19/h3-6,12,17,20H,7-9H2,1-2H3/t12-,17+,18+/m1/s1
Chave InChI:InChIKey=ZKLXUUYLEHCAMF-UUWFMWQGSA-N
SMILES:OC1=CC=C2C3=C1OC4C(OC)=CC=C5C(N(C)CCC354)C2
- Sinónimos:
- (5Alpha)-6-Methoxy-17-Methyl-6,7,8,14-Tetradehydro-4,5-Epoxymorphinan-3-Ol
- (5alpha)-6,7,8,14-Tetradehydro-4,5-epoxy-6-methoxy-17-methylmorphinan-3-ol
- (5α)-6,7,8,14-Tetradehydro-4,5-epoxy-6-methoxy-17-methylmorphinan-3-ol
- 6,7,8,14-Tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methyl-morphinan-3-ol
- Brn 0046094
- DEA No. 9330
- Morphinan-3-ol, 6,7,8,14-tetradehydro-4,5-alpha-epoxy-6-methoxy-17-methyl-
- Morphinan-3-ol, 6,7,8,14-tetradehydro-4,5-epoxy-6-methoxy-17-methyl-, (5α)-
- Morphinan-3-ol, 6,7,8,14-tetradehydro-4,5α-epoxy-6-methoxy-17-methyl-
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Oripavine REF: 61-LGCFOR0037.13CAS: 467-04-9 | - - - | 278,00 € | Seg 16 Dez 24 | |
6,7,8,14-Tetradehydro-4,5α-epoxy-6-methoxy-17-methylmorphinan-3-ol (Oripavine) REF: 86-MM0037.13CAS: 467-04-9 | - - - | 1.064,00 €~1.877,00 € | Qua 18 Dez 24 | |
Oripavine REF: TR-O675000CAS: 467-04-9 | - - - | 123,00 €~707,00 € | Sex 27 Dez 24 | |
Oripavine REF: 3D-O-0050CAS: 467-04-9 | Reported | 136,00 €~647,00 € | Sex 27 Dez 24 | |
Oripavine (1.0mg/ml in Acetonitrile) REF: TR-KIT6715CAS: 467-04-9 | - - - | - - - | Produto descontinuado |
Oripavine
Produto ControladoRef: 61-LGCFOR0037.13
10mg | 278,00 € |
6,7,8,14-Tetradehydro-4,5α-epoxy-6-methoxy-17-methylmorphinan-3-ol (Oripavine)
Produto ControladoRef: 86-MM0037.13
25mg | 1.064,00 € | ||
100mg | 1.877,00 € |
Oripavine
Produto ControladoRef: TR-O675000
5mg | 123,00 € | ||
25mg | 330,00 € | ||
100mg | 707,00 € |
Oripavine
Produto ControladoRef: 3D-O-0050
1g | 647,00 € | ||
50mg | 136,00 € | ||
100mg | 194,00 € | ||
250mg | 364,00 € | ||
500mg | 485,00 € |
Oripavine (1.0mg/ml in Acetonitrile)
Produto ControladoRef: TR-KIT6715
5x1ml | Descontinuado | Solicitar informações |